4902 コニカミノルタ

4902
2024/05/24
時価
2292億円
PER 予
-倍
2010年以降
赤字-64.04倍
（2010-2024年）
PBR
0.42倍
2010年以降
0.23-1.59倍
（2010-2024年）
配当 予
0%
ROE 予
0%
ROA 予
0%
資料
Link
CSV,JSON

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member、Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member、確定給付制度の再測定（税引後）

【期間】
年度Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment MemberResearch And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member確定給付制度の再測定（税引後）
2018/09--2.78億
2019/09---4.07億 赤転
2020/09---16.6億 赤拡
2021/09--0.21億 黒転
2022/09--27億 大幅増
2023/09---36億 赤転

2018年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
2億7800万

2019年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
-4億700万

2020年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
-16億5800万

2021年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
2100万

2022年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
27億300万

2023年9月

Research And Development Expenses Research And Development Activities - Industrial Business Reportable Segment Member
-
Research And Development Expenses Research And Development Activities - Healthcare Business Reportable Segment Member
-
確定給付制度の再測定（税引後）
-35億9700万